The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
U‐251 revisited: genetic drift and phenotypic consequences of long‐term cultures of glioblastoma cells
Open accessAbstract
It is well known that in vitro subculture represents a selection pressure on cell lines, and over time this may result in a genetic drift in the cancer cells. In addition, long‐term cultures harbor the risk of cross‐contamination with other cell lines. The consequences may have major impact on experimental results obtained in various laboratories, where the cell lines no longer reflect the original tumors that they are supposed to represent. Much neglected in the scientific community is a close monitoring of cell cultures by regular phenotypic and genetic characterization. In this report, we present a thorough characterization of the commonly used glioblastoma (GBM) model U‐251, which in numerous publications has been wrongly identified as U‐373, due to an earlier cross‐contamination. In this work, the original U‐251 and three subclones of U‐251, commonly referred to as U‐251 or U‐373, were analyzed with regard to their DNA profile, morphology, phenotypic expression, and growth pattern. By array comparative genomic hybridization (aCGH), we show that only the original low‐passaged U‐251 cells, established in the 1960s, maintain a DNA copy number resembling a typical GBM profile, whereas all long‐term subclones lost the typical GBM profile. Also the long‐term passaged subclones displayed variations in phenotypic marker expression and showed an increased growth rate in vitro and a more aggressive growth in vivo. Taken together, the variations in genotype and phenotype as well as differences in growth characteristics may explain different results reported in various laboratories related to the U‐251 cell line.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00536.x · Cited by 569
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1×
“According to a comprehensive list of misidentified cell lines published by Capes-Davis and colleagues [8], the U-251 cell line has also cross-contaminated the so called human gliosarcoma cell line KNS-89 and the human GBM cell lines SNB-19 and TK-1 (http://www.”
BackgroundGillet, J.-P., Calcagno, A. M., Varma, S., Marino, M., Green, L. J., Vora, M. I., Patel, C., Orina, J. N., Eliseeva, T. A., Singal, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111840108 · Cited by 477 · cited 2×
“Furthermore, in a comparative study to investigate the multidrug resistance transcriptome of various cancer cell types, no correlation was found between clinical samples and established cancer cell lines [25].”
BackgroundCell line misidentification: the beginning of the end
American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266
DNA fingerprinting of the NCI-60 cell line panel
Lorenzi, P. L., Reinhold, W. C., Varma, S., Hutchinson, A. A., Pommier, Y., Chanock, S. J., & Weinstein, J. N. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0921 · Cited by 166
Cancer cell line identification by short tandem repeat profiling: power and limitations
Parson, W., Kirchebner, R., Mühlmann, R., Renner, K., Kofler, A., Schmidt, S., & Kofler, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3062fje · Cited by 129
(2009) · Nature · doi:10.1038/457935b · Cited by 42
Cited by
Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection
Srinivasan, S., Guha, M., Kashina, A., & Avadhani, N. G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.004 · Cited by 436
Poynton, F. E., Bright, S. A., Blasco, S., Williams, D. C., Kelly, J. M., & Gunnlaugsson, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00680b · Cited by 421
Are cancer cells really softer than normal cells?
Alibert, C., Goud, B., & Manneville, J. (2017) · Biology of the Cell · doi:10.1111/boc.201600078 · Cited by 366
Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling
Chaicharoenaudomrung, N., Kunhorm, P., & Noisa, P. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i12.1065 · Cited by 360
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 345
Metadata
- Authors
- Torsvik, A., Stieber, D., Enger, P. Ø., Golebiewska, A., Molven, A., Svendsen, A., Westermark, B., Niclou, S. P., Olsen, T. K., Chekenya Enger, M., & Bjerkvig, R.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2014-05-08
- Volume
- 3
- Issue
- 4
- Pages
- 812-824
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2029728492
- Cited by
- 179
- References
- 7
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.